Clinical Trial Update: Cannabidiol and Prolonged Exposure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cannabidiol in combination with prolonged exposure therapy for PTSD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: VA Office of Research and Development | Conditions: PTSD | Phase 2 | Status: COMPLETED